VALENCIA, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced the appointment of Nicole Linda Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary, effective July 1, 2024. Ms. Kelsey has more than two decades of executive legal... Read More

Voluntary Chapter 11 Commenced to Finalize Consensual Go-Forward Plan for Amyris' Core Business $190 Million Financing Commitment from Foris Ventures to Support Day-to-Day Operations EMERYVILLE, Calif. , Aug. 9, 2023 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris" or the "Company"), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™... Read More

EMERYVILLE, Calif. , June 26, 2023 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced that John Melo has resigned from his role as President & Chief Executive Officer and a member of the Board of Directors, effective immediately.... Read More

EMERYVILLE, Calif. , June 5, 2023 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market TM technology platform and clean beauty consumer brands, today announced that its Board of Directors has engaged the Business Recovery Services unit of PricewaterhouseCoopers ("PwC") and established a subcommittee of... Read More

EMERYVILLE, Calif. , May 19, 2023 Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced that it has signed an exclusive license agreement with British specialty chemicals company Croda International Plc, ("Croda") for the supply of sustainable... Read More

Core revenue of $56.1 million exceeded Q1 guidance of $49.9 million Cash operating expense down 4% compared to Q1 2022 and down 24% versus Q4 2022 Completed strategic partnership with Givaudan on April 3 for $200 million upfront cash EMERYVILLE, Calif. , May 9, 2023 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its... Read More

EMERYVILLE, Calif. , May 2, 2023 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced that it will issue its financial results for the first quarter ended March 31, 2023 , on the afternoon of Tuesday, May 9, 2023 , after closing of... Read More

EMERYVILLE, Calif. , April 24, 2023 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market ™ technology platform and clean beauty consumer brands, provided an update on first quarter revenue. The Company expects to deliver Q1 2023 total revenue of approximately $56 million . The Company previously guided... Read More

Leveraging Amyris' industry-leading biotechnology platform in Beauty for the development and supply of clean sustainable ingredients EMERYVILLE, Calif. , April 5, 2023 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, announced that it has... Read More

Fourth quarter Consumer revenue of $52.8 million increased 64% over the prior year and was another record quarter. Core revenue of $75.8 million grew 17% over the prior year Full year Consumer revenue of $176.9 million increased 92% and outperformed prestige beauty industry growth of 15%. Core revenue of $269.8 million grew 44% over prior year Use of cash for operating and investing activities sequentially improved each... Read More

EMERYVILLE, Calif. , Feb. 28, 2023 /PRNewswire/ -- Amyris, Inc . (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced that it will issue its financial results for the fourth quarter and full year ended December 31, 2022 , on the afternoon of Wednesday, March 15,... Read More

The bio-based sustainable blockbuster ingredients Squalane, Hemisqualane and Cleanscreen as well as development of future cosmetic ingredients from Amyris will accelerate both companies' leadership in biofermentation-based chemistry for the beauty industry. EMERYVILLE, Calif. , Feb. 22, 2023 /PRNewswire/ -- As part of its 2025 strategy to provide new and superior product offerings to expand its Active Beauty business,... Read More

EMERYVILLE, Calif. , Jan. 30, 2023 /PRNewswire/ -- Amyris , Inc. ( Nasdaq : AMRS ), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced the launch of 4U by Tia TM , a new haircare line available exclusively at Walmart . Founded by actress and entrepreneur Tia Mowry , 4U by Tia will be sold in over 2,800... Read More

EMERYVILLE, Calif. , Jan. 4, 2023 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that management will present at the 41st Annual J.P. Morgan Health Care Conference on Wednesday, January 11, 2023 , at 11:15 am PT ( 2:15 pm ET ) in San Francisco . A live webcast... Read More

EMERYVILLE, Calif. , Dec. 29, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that it has entered into a definitive purchase agreement for the purchase and sale of 20,000,000 shares of the Company's common stock and warrants to purchase up to an aggregate... Read More

EMERYVILLE, Calif. , Dec. 27, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market TM technology platform today announced that it has completed the negotiation of key financial and business terms of the previously communicated strategic transaction for the exclusive rights to supply two of Amyris'... Read More

EMERYVILLE, Calif. , Nov. 28, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced record consumer sales performance during this year's Black Friday sales week from Friday, November 18 through Saturday, November 26 . The beauty category, including cosmetics,... Read More

Sixth consecutive quarter of record consumer revenue – Consumer revenue of $46.6 million increased 98% compared to Q3 2021 Record core revenue of $71.1 million grew 49% compared to the prior year quarter "Fit to Win" revenue, cost and cash actions deliver $10 million in Q3 $180 million of new funding closed - strategic transaction on track to self-fund growth EMERYVILLE, Calif. , Nov. 8, 2022 /PRNewswire/ -- Amyris, Inc.... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market TM technology platform and clean beauty consumer brands, today announced that it will issue its financial results for the third quarter ended September 30, 2022 , on the afternoon of Tuesday, November 8, 2022 , after closing of the financial markets. The company will... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced a partnership with World Wildlife Fund (WWF), one of the world's leading conservation organizations, to support WWF's efforts to improve ocean health and reduce the impact of fishing on shark... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, announces the launch of two new brands under its growing consumer portfolio: Stripes ™ , a (peri)menopausal wellness brand founded in partnership with actress, entrepreneur and activist, Naomi Watts , and EcoFabulous ™ , a clean, sustainable... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced that three of its consumer brands will be included in Sephora's launch in the United Kingdom (UK). When Sephora launches its UK website on October 17 th , three Amyris brands – Biossance, JVN Hair... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced that management will participate in fireside chats moderated by equity research analysts, and provide updates, at two upcoming investor conferences: H.C. Wainwright 24th Annual Global Investment... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market TM technology platform and clean beauty consumer brands, published today its 2021 Environmental, Social, and Governance ("ESG") report, highlighting the company's commitment to leading the worlds transition to clean, sustainable chemistry. "Sustainability is at the... Read More

Record consumer revenue of $43 million increased 108% compared to Q2 2021 Ingredients sold out in first half with $15 million backlog to be supplied in H2 Cost actions and price increases to deliver $50 million of EBITDA improvements in H2 $700 million non-equity funding and earnout provides liquidity to sustained profitability Amyris, Inc . (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that management will participate in a fireside chat at the UBS Genomics 2.0 and MedTech Innovations Summit on Wednesday, August 10, 2022 , at 3:00 pm PT / 6:00 pm ET in Dana Point, CA. Speaking on behalf of Amyris will be Sunil... Read More

Amyris, Inc . (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that it will issue its financial results for the second quarter ended June 30, 2022 , on the morning of Tuesday, August 9, 2022 , prior to the opening of the financial markets. The company will hold a conference call and webcast... Read More

VegTech™ Invest, Advisor to EATV , the VegTech™ Plant-based Innovation & Climate ETF, throws historic party at The New York Stock Exchange celebrating the EATV listing and world's first Plant-based Innovation ETF, (NYSE: EATV). EATV (NYSE: EAT V ), the V egTech™ Plant-based Innovation & Climate ETF, made history on June 23 rd... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that it has successfully started fermentation at its new precision fermentation plant in Barra Bonita, Brazil . The greenfield site at Barra Bonita establishes Amyris as the leading manufacturer of highly engineered organisms at... Read More

Amyris, Inc . (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that management will participate in a virtual fireside chat at the Oppenheimer 22nd Annual Consumer Conference on Tuesday, June 14, 2022 , at 11:15 am ET . A live webcast of the presentation and a replay will be available on the... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that management is participating in fireside chats at the following investor conferences this week: Morgan Stanley Sustainable Futures Conference, Monday, May 23 at 2:00 PM ET (virtual) Cowen 6th Annual Future of the Consumer... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market TM technology platform, today announced that management will participate in fireside chats at the following upcoming investor conferences. Morgan Stanley Sustainable Futures Conference, May 23 at 2:00 PM ET (virtual) UBS Global Healthcare Conference, May 25 at 11:30... Read More

Record consumer revenue of $34.6 million increased 121% compared to Q1 2021 Barra Bonita commissioning on track to commence ingredients production in Q2 Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market TM technology platform, today announced financial results for the first quarter ended March 31, 2022 . "We... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that it will issue its financial results for the first quarter ended March 31, 2022 , on the morning of Tuesday, May 10, 2022 , prior to the opening of the financial markets. The company will hold a conference call and webcast at... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, successfully hosted an in-person investor event following the Company's Nasdaq Opening Bell Ringing Ceremony. The investor event, which took place... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that it has started the commissioning of its new fermentation plant in Barra Bonita, Brazil . The greenfield site at Barra Bonita... Read More

Calculated and Distributed by Morningstar Indexes, the Index Defines and Leads a New Global Investment Category in Capital Markets VegTech™ Invest , advisor to the active VegTech™ Plant-based Innovation & Climate ETF (NYSE: EATV) , launches the VegTech™ Plant-based Innovation & Alternative Proteins Index (Ticker EATVI) with... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that management will participate in a fireside chat at the Jefferies Virtual Synthetic Biology Week on Wednesday, March 23, 2022 , at 2:00 pm ET . A live webcast of the presentation and a replay will be available on the Investor... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that it has closed the acquisition of the assets of MenoLabs, LLC, a company founded by women to treat menopause symptoms, drive... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market TM technology platform, today announced financial results for its fourth quarter and full year ended December 31, 2021 . "Accelerating growth of our consumer brands... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that management will participate in a fireside chat at the 42 nd Annual Cowen Health Care Conference on Monday, March 7, 2022 , at 1:30 pm ET . A live webcast of the presentation and a replay will be available on the Investor... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that it will issue its financial results for the fourth quarter and full year ended December 31, 2021 , on the morning of Tuesday, March 1, 2022 , prior to the opening of the financial markets. The company will hold a conference... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ operating platform today announced that it has closed the acquisition of EcoFabulous, a Gen Z-focused clean beauty consumer brand. Amyris also announced the start of... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ operating platform announces that it has agreed to exclusive terms to acquire the assets of MenoLabs, LLC, a women-founded company to treat menopause symptoms, drive... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ operating platform, today announced that management will present at the 40 th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 , at 11:15 am ET... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market ™ operating platform, and ImmunityBio (Nasdaq: IBRX), a clinical-stage immunotherapy company, today announced the completion of a previously announced joint venture agreement to... Read More

Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market TM operating platform, today announced the completion of a previously announced joint venture agreement with MF 92 VENTURES LLC ("Minerva"), a Minerva Foods subsidiary, to develop molecules for the sustainable production and distribution of animal protein... Read More

Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market ™ operating platform, today announced strong year-over-year consumer sales performance during this year's Black Friday sales week. Consumer sales for Black Friday week exceeded $10 million , more than doubling last year's performance and representing the best week of... Read More

Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market ™ operating platform, today announced that management will participate in a fireside chat at the Evercore ISI 4 th Annual HealthCONx Conference on Wednesday, December 1... Read More

Amyris, Inc. , (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market ™ operating platform, today announced that it will host a conference call and live webcast to discuss its recent financing activity on Monday, November 22, 2021 beginning at 6:00 a.m. Pacific Time ( 9:00 a.m. Eastern Time ), John Melo , President and Chief Executive Officer, and... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market TM operating platform, announced that it has closed its offering of 1.50% convertible senior notes due 2026 (the "notes"), for gross proceeds of $690.0 million . The proceeds include the full exercise of the $90.0 million option granted by Amyris to the initial purchasers of the... Read More

Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market TM operating platform, today announced that it has priced $600.0 million aggregate principal amount of 1.50% convertible senior notes due 2026 (the "notes"). The size of... Read More

Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market ™ operating platform, today announced that it proposes to offer $400.0 million aggregate principal amount of convertible senior notes due 2026 (the "notes"), subject to market conditions and other factors. The notes are to be offered and sold in a private placement to... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market TM operating platform, today announced financial results for its third quarter ended September 30, 2021 . "Amyris delivered another strong quarter along with solid strategic... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market TM operating platform, today announced it has entered into a 50:50 joint venture arrangement with ImmunityBio, Inc. (Nasdaq: IBRX), a clinical-stage immunotherapy company, to accelerate the commercialization of a leading next-generation COVID-19 vaccine. The parties have signed a... Read More

Amyris, Inc. , (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it will issue its financial results for the third quarter ended September 30, 2021 after the close of the financial markets on Monday, November 8, 2021 . The company will hold a conference... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that Amyris has licensed the Onyx genome engineering platform from Inscripta, a leading gene editing... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, successfully hosted the fourth webinar in its virtual investor mini-series. The investor mini-series entitled "Lab-to-Market, Delivering Disruptive Health and Beauty Products" was conducted via live webcast and... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in the Clean Health, Beauty and Wellness markets, today announced that it will host its fourth virtual investor webinar on Tuesday, September 28, 2021 . This fourth webinar titled "Lab-to-Market, Delivering Disruptive Health and Beauty Products" will be conducted via live webcast and teleconference on Tuesday, September 28, 2021 at 1:00 pm ET ( 10:00 am... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that management will present at two upcoming investor conferences and provide a business update. H.C. Wainwright 23 rd Annual Global Investment Conference, September 13 from 7:00 AM ET for on-demand viewing Cowen's 2nd... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that, on August 31 , it closed the acquisition of Beauty Labs International Ltd. ("Beauty Labs"), a leader in AI... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch of JVN™, a clean hair products brand. Today's launch is the third of three highly anticipated brand launches Amyris is introducing to the market this summer. The JVN haircare line is a collaboration between... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it closed the acquisitions of OLIKA, Inc. (OLIKA), an award-winning clean consumer brand, and MG Empower Ltd., a... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch of Rose Inc., a clean color cosmetics brand. Today's launch is the second of three highly anticipated brand launches Amyris is introducing to the market this summer. Amyris and Rosie... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced promising in-vivo results in a study of its licensed RNA vaccine through intranasal delivery, developed in... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch of Terasana ™ Clinical, a clean skincare brand. Today's launch represents the first of three highly... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, announced today that it will be hosting an encore to its first three-part virtual investor mini-series themed "Delivering... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced financial results for its second quarter ended June 30, 2021 . "With Q2 we completed another... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that John Melo , President and Chief Executive Officer, will present at the Oppenheimer 24th... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced a partnership with Naomi Watts to create a new consumer brand to provide science-backed, menopause... Read More

Amyris, Inc. , (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it will issue its financial results for the second quarter ended June 30, 2021 on the... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today released its first Environmental, Social and Governance (ESG) report, underscoring the company's founding commitment to making people and the planet healthier. With its leading Lab-to-Market™ science and... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it has signed an exclusive license with Nant Africa , LLC relating to the development and use of the... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced partnerships with the UNCF (United Negro College Fund) and 10,000 Degrees ® to establish a $180,000 scholarship fund to support Black and African American students... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced that John Melo , President and Chief Executive Officer, will participate at the Jefferies Virtual Consumer Conference on Wednesday, June 23 rd at 3:15 pm ET . A live... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it has executed a binding term sheet for the acquisition of award-winning, clean wellness company... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced that John Melo , Director, President and Chief Executive Officer, will participate in a virtual fireside chat at the Morgan Stanley 6th Annual Sustainable Futures... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it has obtained commitments for over 10,000 new doors at retail stores such as Sephora North America ,... Read More

&vest, an investment platform founded in 2019 focused on SPACs and private investments, today announced that Bill Hinman has joined the company as Partner. Hinman served as Director of Corporation Finance at the U.S. Securities and Exchange Commission (SEC) from 2017 to 2020, where he was primarily responsible for overseeing regulations and processes for initial public offerings and other corporate disclosures. During his... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced that management will participate in a fireside chat at the virtual Morgan Stanley Global Consumer Ingredients Day on Tuesday, May 18 th at 10:45 am ET . A live... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced financial results for its first quarter ended March 31, 2021 . "We delivered significant value during the first quarter from continued product-related revenue growth... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that Pipette™, its clean baby and mothers skincare brand, will partner with non-profit organization, Baby2Baby to donate 200,000 units of its award-winning hand sanitizer to families living in poverty nationwide. During... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it has signed an agreement with Ingredion Incorporated (NYSE: INGR), a leading global ingredient... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, successfully hosted the third webinar in its virtual investor mini-series themed "Delivering on the Promise of Synthetic... Read More

Amyris, Inc. , (Nasdaq: AMRS) a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it will issue its financial results for the first quarter ended March 31, 2021 on Thursday, May 6, 2021 prior to the opening of the financial markets. The company will hold a conference call and live... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it has executed a binding term sheet for the acquisition of Gen Z-focused beauty brand, EcoFabulous... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it has agreed to acquire Beauty Labs International Ltd. ("Beauty Labs"), a leader in AI technology that... Read More

Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the pricing of an underwritten public offering of an aggregate of 19,047,619 shares of its common stock at a public offering price of $15.75 per share, which consists of a secondary offering of... Read More

Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the commencement of a proposed underwritten public offering of shares of its common stock. Amyris... Read More

Amyris, Inc. , (Nasdaq: AMRS) a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced a 5-year partnership with Reese Witherspoon as global brand ambassador for Biossance ® , one of the fastest growing clean and sustainable skincare brands in the world. Together, Reese and Biossance will... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that management will participate in a fireside chat at Cowen's 2 nd Annual Consumer Platforms for the Next Generation Summit on Tuesday, April 6 th at 9:30 am ET . A live webcast of the presentation and a... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it will host the third webinar in its virtual investor mini-series themed " Delivering on the Promise of Synthetic Biology. " This third webinar entitled " Science and Partnerships, Building Blocks for... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it has signed and closed an agreement with DSM Nutritional Products Ltd., a subsidiary of Royal DSM... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, announced today the achievement of another breakthrough with its production of Cannabigerol (CBG) from fermentation for... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, announced today that it has signed a memorandum of understanding for a partnership with Minerva Foods of Brazil to develop... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that management will participate in a fireside chat at the virtual 33 rd Annual Roth Conference on... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, announced today that its clean sweetener consumer brand, Purecane ™ , has been named to Fast Company's World's Most Innovative Companies list for 2021. Fast Company honors businesses that found a way to be resilient in the... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced financial results for its fourth quarter and full year ended December 31, 2020 . "2020 was a year of transformative execution for Amyris," said John Melo , President... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, announces that it has entered into an agreement to acquire Costa Brazil. Amyris is accelerating its growth and market... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced that members of its management team will participate in two upcoming investor conferences: Cowen 41 st Annual Health Care Conference, March 4 at 12:10 PM ET H.C. Wainwright Global Life Sciences Conference, March 9 at 1:30 PM ET A webcast of the presentations and... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that its Pipette ® clean baby care brand will expand its brick and mortar retail presence in more than 600 Target stores across North America beginning in March 2021 . Since launching in 2019, Pipette clean... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced highly promising preliminary data in a pre-clinical study of its ribonucleic acid (RNA) COVID-19 vaccine platform as well as the potential to address current manufacturing, supply scale-up and refrigerated... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2020 on Tuesday, March 2, 2021 , prior to the opening of the financial markets. The company will hold a conference call and live audio webcast at 6:00 am Pacific Time (... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, successfully hosted the second webinar in its virtual investor mini-series themed "Delivering on the Promise of Synthetic Biology." This second webinar entitled " The Science Delivering Clean and Sustainable Consumer... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it will host the second webinar in its virtual investor mini-series themed " Delivering on the Promise of Synthetic Biology". This second webinar entitled " The Science Delivering Clean and Sustainable... Read More

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced breakthrough results in an early clinical study of Amyris's clean topical formulation of fermentation-based ingredients for the treatment of acne. In the study which was conducted by Princeton Consumer... Read More